(Updated - January 4, 2023 8:11 AM EST)

UBS analyst Markus Mittermaier downgraded Emerson (NYSE: EMR) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE